Aleksandra Kubica-Misztal has a diverse work experience in various roles and organizations. Aleksandra is currently a member of the Board and Founder of diCELLa since October 2022. Prior to that, they served as the CEO and Founder of diCELLa from November 2017 to September 2022. Aleksandra also worked at Yellow House English S.A. as the R&D Director from October 2022 and previously as the R&D Project Manager from January 2021 to September 2022. In addition, they co-founded ai2device in November 2020 and worked as a Co-Founder. Before that, they worked at Voxel SA as an R&D Project Manager starting from August 2018.
Aleksandra'scareer began at Jagiellonian University, Center for Technology Transfer CITTRU, where they worked in different roles including Transfer Technology Officer from May 2015 to December 2017, PhD student from October 2010 to July 2017, and Project Manager and Researcher from August 2013 to August 2016. Aleksandra also had an internship at Jagiellonian University, Center for Transfer Technology CITTRU from November 2014 to January 2015.
Additionally, Aleksandra gained international experience through visiting student positions at University of Bayreuth in 2014 and 2012, Stockholm University in 2013 and 2011. During their time at Stockholm University in 2011, they contributed to a publication on quantum chemistry calculations for Nickel complexes.
Aleksandra Kubica-Misztal has a diverse education history spanning multiple fields of study. Aleksandra obtained their Master's degree in Medical Physics from Jagiellonian University, graduating in 2010. Aleksandra then pursued a PhD in Biophysics at the same institution from 2010 to 2014. Additionally, Aleksandra completed postgraduate studies in Business in Biotechnology at Jagiellonian University from 2012 to 2013, and in Financial Mathematics at AGH University of Krakow from 2011 to 2012.
In 2017, Aleksandra enrolled in a post-graduate program at Krakowska Szkoła Biznesu UEK | Cracow School of Business CUE, focusing on the analysis of financial markets and investment consulting. Aleksandra completed this program in 2018.
Aside from formal degrees, Aleksandra has obtained several certifications. In 2014, they received a certification in the practical aspects of designing, monitoring, and analyzing randomized clinical trial results from the Małopolska Translational Medicine Centre. In 2011, they achieved a certification in technology transfer and valuation from Malopolska Regional Development Agency S.A. Aleksandra also obtained a certification in the valuation of patent rights and commercialization of innovations in 2021, with the speaker being Andrzej Półkoszek.
Additionally, Aleksandra has pursued further training in clinical trials monitoring. Aleksandra has completed both Clinical Trials Monitoring Advanced and Clinical Trials Monitoring Basics courses with Soft Communication, although the specific dates of these certifications are not provided.
Sign up to view 0 direct reports
Get started